From: Cost-effectiveness analysis of fruquintinib for metastatic colorectal cancer third-line treatment in China
Strategy
Fruquintinib
Placebo
Cost, USD
20,750.9
12,042.2
Effect, QALY
0.6404
0.4776
IC, USD
8708.7
–
IE, QALY
0.16275
ICER, USD per QALY
53,508.7